Medpharmics, LLC

Gulfport, Mississippi 39503-2637

1 studies enrolling now · 12 studies all time

What they study most

COVID-19, COVID-19 Prevention, Clostridium Difficile Associated Disease, Cytomegalovirus Infection, Episodic Migraine, Infant Development, Migraine, Obesity, Overweight, Pneumococcal Disease, Recurrent C. Difficile Infection, Respiratory Tract Infection

Studies at this site

• A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities — Recruiting now
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed
• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
• A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) — Completed
• Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants — Completed
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
• Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age — Completed
• Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study — Completed
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
• A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) — Stopped early
• A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN — Completed
• Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas — Completed